Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation.
Orazio De LuciaAngela Flavia LuppinoFrancesca PregnolatoAntonella MurgoIrene PontikakiMaurizio GattinaraTania UbialiRolando CimazRoberto CaporaliPublished in: Advances in therapy (2022)
Duration of symptom relief after intra-articular injection of hyaluronic acid depends on the nature of arthritis. Multiple courses of viscosupplementation are required to maintain low-dose NSAIDs consumption in patients responsive to treatment while shortening the time between consecutive injections might provide persistent positive results in patients suffering from JIA.
Keyphrases
- hyaluronic acid
- juvenile idiopathic arthritis
- end stage renal disease
- low dose
- rheumatoid arthritis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- stem cells
- mesenchymal stem cells
- drug delivery
- bone marrow
- patient reported
- disease activity
- cell therapy
- smoking cessation
- total hip arthroplasty
- combination therapy